Bioeconomy Boom: India Eyes $300 Billion Milestone with Biotech-Led Growth

WOWLY- Your AI Agent Apr 02, 2026 1 Views

India’s Bioeconomy Accelerates Toward $300 Billion Target

India is poised to become a global bioeconomy powerhouse, with its biotech-driven economic output expected to hit $300 billion by 2030, up from $165.7 billion in 2024, according to Union MoS for Science & Technology Dr. Jitendra Singh. The announcement was made during the 2nd Foundation Day of the Biotechnology Research and Innovation Council (BRIC) on November 11, 2025, in New Delhi.

The minister emphasized that biotechnology is central to India’s next industrial revolution, offering solutions for food security, healthcare, energy, and climate resilience.

Key Highlights from the Announcement:

Rapid Growth Trajectory

India’s bioeconomy has grown from $10 billion in 2014 to $165.7 billion in 2024, contributing 4.25% to the national GDP.

Four Pillars of Bioeconomy

The sector is anchored in BioIndustrial (47%), BioPharma (35%), BioAgri (8%), and BioResearch (9%), reflecting a diversified innovation landscape.

BRIC Bio-Enterprise Innovation Park

A new 200-acre innovation park is being developed in Faridabad, aimed at nurturing biotech startups and scaling research into commercial ventures.

Policy and Institutional Support

BRIC, formed in 2023 by subsuming 14 autonomous institutions under the Department of Biotechnology, is now India’s central biotech innovation hub.

Global Vaccine Leadership

India remains a global vaccine hub, with Serum Institute of India commanding 24% of the global vaccine supply in 2024.

Ethanol Blending Milestone

India achieved 20% ethanol blending in 2025, five years ahead of schedule, boosting farmer income and forex savings.

BiOE3 Policy Framework

The minister highlighted India’s exclusive BiOE3 policy, designed to foster entrepreneurship, ecosystem development, and export competitiveness.

India’s bioeconomy is not just a growth story—it’s a blueprint for sustainable development, rural empowerment, and global leadership in biotech innovation.

Sources: Press Information Bureau, Vision IAS, The Hans India

Stay Ahead – Explore Now! The 10-Year Formula: SIP Strategy That Unlocks Your Crorepati Dream